1. Home
  2. KLIC vs RCUS Comparison

KLIC vs RCUS Comparison

Compare KLIC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kulicke and Soffa Industries Inc.

KLIC

Kulicke and Soffa Industries Inc.

HOLD

Current Price

$79.75

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.60

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLIC
RCUS
Founded
1951
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2004
2018

Fundamental Metrics

Financial Performance
Metric
KLIC
RCUS
Price
$79.75
$23.60
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$54.67
$30.27
AVG Volume (30 Days)
512.4K
844.5K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.03%
N/A
EPS Growth
100.32
N/A
EPS
0.32
N/A
Revenue
$654,081,000.00
$247,000,000.00
Revenue This Year
$45.81
N/A
Revenue Next Year
$11.35
$83.23
P/E Ratio
$249.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.22
$7.06
52 Week High
$80.97
$26.40

Technical Indicators

Market Signals
Indicator
KLIC
RCUS
Relative Strength Index (RSI) 70.75 56.38
Support Level $61.26 $20.18
Resistance Level N/A $24.33
Average True Range (ATR) 2.94 1.07
MACD 1.47 0.16
Stochastic Oscillator 95.91 85.79

Price Performance

Historical Comparison
KLIC
RCUS

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: